Literature DB >> 7714109

Genetic alterations in thyroid hyperfunctioning adenomas.

D Russo1, F Arturi, R Wicker, G D Chazenbalk, M Schlumberger, J A DuVillard, B Caillou, R Monier, B Rapoport, S Filetti.   

Abstract

Thirty-seven thyroid autonomously hyperfunctioning adenomas were screened for mutations in the TSH receptor (TSHR), G alpha s (gsp), and ras genes. Polymerase chain reaction-amplified fragments of the TSHR C-terminal part (exon 10), the G alpha s (exons 8 and 9), and the three ras genes were obtained from the genomic DNA extracted from 37 tumors and their adjacent normal tissues and were studied by direct nucleotide sequencing and hybridization with synthetic probes. A point mutation in the third intracellular loop (codon 623) of the TSHR was found in 3 of 37 adenomas studied. This mutation codes for a change (Ala to Ser) in the TSHR structure and is somatic and heterozygotic. Constitutive activation of the TSHR was demonstrated by an increase in basal cAMP levels after transfection of Chinese hamster ovary cells with a mutated Ser623-TSHR complementary DNA. Nine gsp[00ae]MDRV[00af]- and one ras-activating mutations were also detected. No simultaneous alteration of the studied genes was present. Thus, in hyperfunctioning thyroid adenomas, our data suggest that a mutational activation of the TSHR and gsp genes may play a tumorigenic role through constitutive activation of the cAMP pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7714109     DOI: 10.1210/jcem.80.4.7714109

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Molecular insights into TSH receptor abnormality and thyroid disease.

Authors:  D Russo; F Arturi; E Chiefari; S Filetti
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

2.  Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.

Authors:  P Kopp; S Muirhead; N Jourdain; W X Gu; J L Jameson; C Rodd
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  Similarities and differences in the phenotype of members of an Italian family with hereditary non-autoimmune hyperthyroidism associated with an activating TSH receptor germline mutation.

Authors:  F Arturi; E Chiefari; S Tumino; D Russo; S Squatrito; G Chazenbalk; L Persani; B Rapoport; S Filetti
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

Review 4.  [Thyroid tumors].

Authors:  K W Schmid; S-Y Sheu; R Görges; C Ensinger; M Tötsch
Journal:  Pathologe       Date:  2003-09       Impact factor: 1.011

5.  The curious case of Gαs gain-of-function in neoplasia.

Authors:  Giulio Innamorati; Thomas M Wilkie; Havish S Kantheti; Maria Teresa Valenti; Luca Dalle Carbonare; Luca Giacomello; Marco Parenti; Davide Melisi; Claudio Bassi
Journal:  BMC Cancer       Date:  2018-03-15       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.